Diffuse posterior leukoencephalopathy in MELAS without stroke-like episodes: A case report

Peng Bai1,2, Yinling Feng1, Jin Chen1

  • 1Department of Neurology, Inner Mongolia People's Hospital, Hohhot, People's Republic of China.

Medicine
|May 5, 2023
PubMed
Abstract

Insights

Mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) can present with white matter lesions without typical stroke-like episodes. This case highlights MELAS syndrome in a patient with diffuse posterior cerebral white matter lesions, emphasizing diagnostic considerations.

Area of Science:

  • Neurology
  • Genetics
  • Neuroimaging

Background:

  • Mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) is a common mitochondrial disease.
  • White matter lesions are increasingly recognized in mitochondrial diseases, not solely in lysosome or peroxisome disorders.
  • Approximately 50% of MELAS patients exhibit white matter lesions, alongside stroke-like episodes.

Observation:

  • A 48-year-old female presented with loss of consciousness and extremity twitching, with a history of epilepsy and diabetes.
  • Brain MRI revealed symmetrical high-intensity lesions in the bilateral parietal and occipital lobes, consistent with white matter abnormalities.
  • Genetic analysis identified the A3243G point mutation in mitochondrial DNA, confirming MELAS syndrome.

Findings:

  • The patient received symptomatic treatment including mechanical ventilation, antiepileptics, and supportive care with vitamins and coenzyme Q10.
  • Following treatment, seizure activity ceased, and the patient showed clinical improvement.
  • The case demonstrated MELAS syndrome presenting with diffuse posterior cerebral white matter lesions without overt stroke-like episodes.

Implications:

  • This case underscores the importance of considering MELAS syndrome in patients with unexplained symmetric posterior cerebral white matter lesions.
  • Early diagnosis and appropriate management, including antioxidant therapy, can lead to improved patient outcomes.
  • Further research into the diverse clinical manifestations of MELAS syndrome is warranted.

Related Concept Videos

Hemorrhagic Stroke l: Introduction01:17

Hemorrhagic Stroke l: Introduction

A hemorrhagic stroke is an acute neurological event that occurs when a weakened cerebral blood vessel ruptures, allowing blood to accumulate within or around the brain. The sudden release of blood forms a focal hematoma that increases intracranial pressure, displaces neural tissue, and can obstruct cerebrospinal fluid pathways. These effects may be compounded by intraventricular extension of the hemorrhage, cerebral edema, or compression of adjacent structures, all of which contribute to...
Encephalitis l: Introduction01:19

Encephalitis l: Introduction

Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Cerebral Edema ll: Pathophysiology01:22

Cerebral Edema ll: Pathophysiology

Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...